> ## Content Index
> Fetch the complete content index at: https://www.fdaweb.com/llms.txt
> Use this file to discover other available public pages before exploring further.

# GAO Finds Gaps in FDA's IT Modernization Planning
- URL: https://www.fdaweb.com/gao-finds-gaps-in-fdas-it-modernization-planning/
- Published: 2026-11-19T17:05:00.000Z
- Updated: 2026-11-20T00:43:15.000Z
- Author: David McFarland
- Tags: FDA Policy/General

FDA has made substantial progress in developing its information technology modernization strategy but needs to strengthen oversight of major investments and track challenges that could jeopardize its goals, according to an [11/18 Government Accountability Office report](https://files.gao.gov/reports/GAO-27-108743/index.html?ref=fdaweb.com).

GAO found that FDA's IT strategic planning documents fully addressed six of eight leading planning practices. However, the agency had not adequately documented how it would monitor key modernization challenges or connect major IT investments and resources to strategic objectives.

FDA reported spending $898 million on IT in fiscal 2025 and approximately $5.4 billion from fiscal 2020 through 2025\. The agency has 17 major IT investments supporting activities including drug reviews, medical device oversight, inspections and adverse-event reporting.

In examining five major investments, GAO found that FDA had established performance measures but could not demonstrate how it used those measures to manage and improve one investment.

GAO made three recommendations addressing the planning and performance-monitoring deficiencies:

  - track key IT modernization challenges described in its IT strategic plan
  - align details of major IT investments and related resources to IT strategic plan goals
  - demonstrate use of performance metrics in managing one of FDA’s major IT investments

HHS agreed with all three and outlined steps to implement them.